Neuromuscular system

The term "Neuromuscular system" refers collectively to the physiological network that enables communication between the nervous system and muscle fibers, executing voluntary movement. However, it is not a *single molecular target* but a complex system typically studied at specific structures like the neuromuscular junction or at the level of receptors (e.g., nicotinic acetylcholine receptor). Therefore, using "Neuromuscular system" as a drug target is scientifically incorrect and nonspecific. The neuromuscular system comprises the entirety of motor neurons (both central and peripheral) and skeletal muscle cells, interconnected at specialized synapses called neuromuscular junctions. It underlies all voluntary muscle contraction by relaying electrical signals from the central nervous system through motor neurons to muscle fibers. The junction itself is a chemical synapse—composed of a motor neuron terminal, a synaptic cleft, and the postsynaptic muscle membrane—where acetylcholine acts as the primary neurotransmitter. Dysfunction anywhere in the neuromuscular system can result in muscle weakness, paralysis, or disorders such as ALS and Myasthenia gravis. As a label, "Neuromuscular system" is too broad, imprecise, and does not correspond to a recognized therapeutic molecular target; correct usage in therapeutic targeting typically refers to specific molecules within the system (e.g., "nicotinic acetylcholine receptor", "acetylcholinesterase", "voltage-gated sodium channel").

Other names

Neuromuscular apparatusNeuromuscular networkNeuro-muscular system